APA (7th ed.) Citation

Rovina, N., Akinosoglou, K., Eugen-Olsen, J., Hayek, S., Reiser, J., & Giamarellos-Bourboulis, E. J. (2020, April). Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Critical Care.

Chicago Style (17th ed.) Citation

Rovina, Nikoletta, Karolina Akinosoglou, Jesper Eugen-Olsen, Salim Hayek, Jochen Reiser, and Evangelos J. Giamarellos-Bourboulis. "Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Predictor of Severe Respiratory Failure in Patients with COVID-19 Pneumonia." Critical Care Apr. 2020.

MLA (9th ed.) Citation

Rovina, Nikoletta, et al. "Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Early Predictor of Severe Respiratory Failure in Patients with COVID-19 Pneumonia." Critical Care, Apr. 2020.